The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer

AMG-510 and cisplatin combination increases antitumor effect in lung adenocarcinoma with mutation of KRAS G12C: a preclinical and translational research

Clinical application of the AMOY 9-in-1 panel to lung cancer patients - ScienceDirect

IJMS, Free Full-Text

Utility of needle biopsy in centrally located lung cancer for genome analysis: a retrospective cohort study, BMC Pulmonary Medicine

Genotype-phenotype mapping of a patient-derived lung cancer organoid biobank identifies NKX2-1-defined Wnt dependency in lung adenocarcinoma - ScienceDirect

Genotype-phenotype mapping of a patient-derived lung cancer organoid biobank identifies NKX2-1-defined Wnt dependency in lung adenocarcinoma - ScienceDirect

CLIP1-LTK fusion: A novel druggable gene fusion in NSCLC,identified using LC-SCRUM-Asia genomic screening platform - A step further to precision medicine

Review: biological implications of oncogenic rearrangements in non-small cell lung cancer - Di Marco - Precision Cancer Medicine

The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancer. - Abstract - Europe PMC